{"name":"Chinook Therapeutics, Inc.","slug":"chinook-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BION-1301","genericName":"BION-1301","slug":"bion-1301","indication":"Hepatocellular carcinoma (HCC), FGFR4-positive","status":"phase_3"}]}],"pipeline":[{"name":"BION-1301","genericName":"BION-1301","slug":"bion-1301","phase":"phase_3","mechanism":"BION-1301 is a monoclonal antibody that targets and inhibits FGFR4 (fibroblast growth factor receptor 4) to reduce hepatocellular carcinoma cell growth and survival.","indications":["Hepatocellular carcinoma (HCC), FGFR4-positive"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNTjB0Y2RBRjlRRjlnYmhIV0ZyTm5GU2toUnpmX19sRW1hZUxvM2hRbjBzQTdoeGQ0dU4wZlZ0OUk5MW1HUHRheFY2bWgza2lqeU00dU84M005Xy1heG1ZTmtNd3RfYlQ1WTROZHU3Zm83SFlDRndEOGcySG5KOEV2RF9iMWtVTVNMemtCd1NmNmptQnZNeFVTRGhTdmNNM0ROLVNkNElLV3ZCdXdBak5UcURSWXlqcFk?oc=5","date":"2025-05-27","type":"pipeline","source":"Fierce Biotech","summary":"5 people charged in $600K insider trading scheme tied to Novartis' Chinook acquisition: DOJ - Fierce Biotech","headline":"5 people charged in $600K insider trading scheme tied to Novartis' Chinook acquisition: DOJ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOb3ZPVG82bTJTam8tQVFEeG04NTFoMEt6Y0Q0YS04VmhJSjNNMS1pQ003TU03djh3Ull1RnFSbERacjB1UC04MlVrRVFUNExwYVRyV3MzVy1qeThNdDBFd2lTckRaZW5zQXlrNVFYX0x3aTlJb0kybkhVb0lmZnprczV1b0sxOXhiVjh4bnpLYWpsWGhWSGVVMXoxWXQ5OHBXR1Bxc1Q0ME5MRDl4TEhvRVlTRzlqMzdyeHI1M2d3TUU1MVNUTEFieXo0b09OMVRjZ2lxWjAtY1FCRHhfMjNOc2ZjZTJJZHlD?oc=5","date":"2025-05-27","type":"pipeline","source":"PR Newswire","summary":"FILSPARI to Transform Kidney Disease Care with Its Revolutionary Treatment Approach | DelveInsight - PR Newswire","headline":"FILSPARI to Transform Kidney Disease Care with Its Revolutionary Treatment Approach | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOVNubC16Ql9HTXoyMzVFR2NOS1JGT01CTUFtSl8xdS1rM05oaFRsQ1hQbUlzUVV3SW9OOWdJNGdfYVByeHVKcndvenVCUTVCNmRxYUpFUWNEa0ZxT1g1eWxPTXk3R01TTDI0UHBrRlZLSmxnVk15emVnYmxTX2NvUEhrUVlLTm9kbW83dndoeEMyQzA1bG1wTTRxb1pueHhud3ZVMGd3ZDdEQkwtb05GMUtIUE91TEs1TXlGRDdqYXI?oc=5","date":"2025-04-03","type":"regulatory","source":"Fierce Pharma","summary":"Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors - Fierce Pharma","headline":"Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPaTlWTW16cE9wVzRkT285UHA3VUhZWDlVcjZWLXY5RkZFdzJrYlM1MzdBQml4MnA3ektXN050emNMZGdRRUNkR0FUV3M0TWFiYklENjVRVEwzNnlyeTVYVlJTejdNSktOZGpiZWdKbzZKNzhQajlFRk05SEhpUFZkZTFlaENXQmprMFozbXFvX0pJQzdPQzNZ?oc=5","date":"2024-08-22","type":"pipeline","source":"BioPharma Dive","summary":"Versant reimagines its Chinook success with newest startup launch - BioPharma Dive","headline":"Versant reimagines its Chinook success with newest startup launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOT0U0UEMyTWZZbDR1aUpWWFJSNlQtSDVweUNtRDAzN2pzUGZzR2hGR190ZnJjQjhoZWt5Q3VCOWtQOHZ2VWMxQkt1X003ME14blZrY2hDa19ZUVRJaWVLYlpsWWNiSWxXMy1GMG9QNmlqUkNYaTJGdEdib0FvR1FjYWhrQmF2Z2NVd0hEUGFUbzlqdlNqUzBPenZDVFNqd0ZVMk1RdldB?oc=5","date":"2023-08-14","type":"deal","source":"Pharmaceutical Technology","summary":"Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline - Pharmaceutical Technology","headline":"Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPMjkzS2d5VVJvQTlSY1laSnhtd0RVTWlmMV8wNTlQUjBwenVMYkN0R2Yya21iZnhYR3FCZXk0OF9yQ3RCWUhMMk4wNnpGU01LZEJYcDVvYWFsbFRXcW5PRGNYYjFYb3dUaVpycktIX3phX2U2d1NuRUFaUG1kRzRyRmlxbnpudDZhWS14NmI4NlBKUXJwSUhqdDlnTlo?oc=5","date":"2023-08-11","type":"pipeline","source":"Novartis","summary":"Novartis completes acquisition of Chinook Therapeutics - Novartis","headline":"Novartis completes acquisition of Chinook Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOZlBWdV9EdHFONHVoNWlPaWdRSTcyVUF4WEV0aDR2QnloZ3BKUHlscy05dFZmX2NSX09QVGVma3MzVXNkaGY2NjctdjhkeVhzZDVsSThYYVhjcTlCRXVWbUtscC11eXNLbnlSQVAzSWwtQ09saTJOTGgtWVg2T1dPNUsyel9TU2pDN1Rwd2JGbTZZeWJZbWF6OG1LczcwZms?oc=5","date":"2023-06-12","type":"deal","source":"reuters.com","summary":"Novartis buys Chinook for $3.5 billion in race to treat rare kidney disease - reuters.com","headline":"Novartis buys Chinook for $3.5 billion in race to treat rare kidney disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxObGVSLVNaVkZ2eGlfUVl1RFcwVlBnRWtLMHJES1RtLS02RHd6UFYzOU5xbUxYY0NiRm8ybVg5OVdRWk5pZUt0VUhSd3RPdkFCV3JqaXlSMFdBSzA4aWdXaTZOcWEzLUY4NW16OEd6Y0FCREZNQjIzVDRQY2dGalNPYWZZZnh2eU9YbXBtOVEzTmtsakNJSW9Xc0hiMnZwbktZbTNV?oc=5","date":"2023-06-12","type":"deal","source":"GeekWire","summary":"Novartis to buy Seattle biotech firm Chinook Therapeutics in $3.2B deal - GeekWire","headline":"Novartis to buy Seattle biotech firm Chinook Therapeutics in $3.2B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQRFYwcmZUUVBfdncteUNFVFJHS2FsSGgxV1BfU0V6YXZ4WG82NDJqaVdraFVuMVltNnp3T2UwdmJYQzhCeHhNN2dydDJlazlCbDBhYTdyUUtialVtYWxwU3NsMkl6cDA0czhmWG00VmFJMDBWMTBVQmlPTG5lemg3bDduY2JWdFA3OUdvNUpzeUZJbjdfMWQzd25OamJXZEdVMmc?oc=5","date":"2023-06-12","type":"deal","source":"Business in Vancouver","summary":"Vancouver biotech Chinook Therapeutics to be acquired for US$3.2B - Business in Vancouver","headline":"Vancouver biotech Chinook Therapeutics to be acquired for US$3.2B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOVTkxbGxnN2daOGxfcVBCZlZxY2EwWUhaNXh3anBoeWJoOHZqOVZmLWZaWm00d011eWpZdnZNVlZmX0ExU1lPdTFGczM5VVV0Q2VVbmxLQk1jOTRQZGNXNHQ3OUNQd3JBLUR6RmEtZk9BdUFBSXRDOFh4bWJSWjBCM2haMXJQV01aWk1YN2NsSXVNeUZKZHF6Qmx4aFFDN19VYWFpWEpIemRCQ0R0YWdDeFRhSU5udHhZQUxFSW5QTXVsdS12QmNhaUZaMjBjSXh5cWJ5Q0sxUDVSUWI3SFBqSUNQNk1uT25aMHgxdzZDd2NsLXdhZjRWSVdvSjF4RzhhTmUwd1VuSXdWZ0pM?oc=5","date":"2023-06-12","type":"deal","source":"Novartis","summary":"Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics for USD 3.2bn upfront (USD 40 / share) - Novartis","headline":"Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics for US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOMXoyLXNiQzE5SDdIZGxnUVJDRnM2ODdOVGJmLWxjdHp6M3VQNTR5Mk9Ncml0SklOSU9vSEJoeHRHekZQdG9ybjQxQkVfcllxR3FGbVNCTXBsaUJjRmJ1ZzFWNW9vdWRpVGFVcVY4V1lORVpzRWRLb25nQmJaa1Ita251THYtUWpBNUhN?oc=5","date":"2023-01-10","type":"pipeline","source":"Pharma Voice","summary":"Chinook Therapeutics nears the finish line in kidney disease - Pharma Voice","headline":"Chinook Therapeutics nears the finish line in kidney disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPajZWazdLX0JkZE01T0R0Sk4yTkktMm9Tc0hNcXlFekV3MnFSOUJWRjhNaG5MYllJNlQtQXZsdDhOdk1ueDBfUEt2RUhZVFVldVo5X3hhN0RxSXZyanJfZFNncW1DRnhndjdldWRPcW1YMlZsUzRhOXo4LWh5M2xyUXl3SzNFYlNaTi1hUGppRDRpYzhGdHlMQ05wQ0c1WHF5M0IwYklETDZfajhERXhzQXhfVXFCS09lQmtxNzVFc3BJeFBZOFZ3LWpra2dtY2dsQV9kcDBJRjRYTnBjMU10cg?oc=5","date":"2020-06-02","type":"deal","source":"globenewswire.com","summary":"Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement - globenewswire.com","headline":"Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}